Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections
about
In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivativeComparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates.Effects of norfloxacin on DNA metabolism in Pseudomonas aeruginosa.Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae.In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in miceβ-Cyclodextrin inclusion complex to improve physicochemical properties of pipemidic acid: characterization and bioactivity evaluation.Multicenter evaluation of the proposed quality control limits and interpretive zone standards for in vitro susceptibility testing with norfloxacinMutations producing resistance to norfloxacin in Pseudomonas aeruginosa.In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa.Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography.Norfloxacin and silver norfloxacin in the treatment of Pseudomonas corneal ulcer in the rabbit.In vitro and in vivo antibacterial activity of AT-2266.Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans.Antibacterial activity of norfloxacin in the gastrointestinal tracts of ratsAntibacterial activity of norfloxacin.Norfloxacin disposition after sequentially increasing oral doses.In vitro antibacterial activity of norfloxacin compared with eight other antimicrobial agents.
P2860
Q24685742-07392BA6-A77D-47FB-A845-AE268817D8D8Q34250608-0F67BB43-B045-4579-8D7B-A9A2E7FC579FQ35648233-3B2F9A13-553E-4572-A5B7-1494AA5A52E5Q35671269-B3498C27-98D6-45B1-ABD0-1B26B8A30E3DQ35739778-8648BC27-5B09-433F-A9E7-F27D8EA100B7Q35742478-596D8B83-0A8D-41C2-837C-ECDEDE888FC1Q37091750-FC115382-B2D2-4914-B52C-85DCEE9ACDD6Q37258777-EB2E18E8-FD78-440A-A226-3350397C56FDQ39827996-B1098AAF-0A9C-45FC-BED9-E9F43C2A1024Q39856897-A8CD78AE-4263-472B-A26F-C81346E4A273Q39857099-54944FA3-F03A-426B-B603-D1EC46512DBCQ40087443-87AE5D8A-A651-4031-B7BC-232827D142EFQ41952207-45ADADD7-3D80-4176-93B2-5001D5B4E758Q42115623-38589B66-1787-4054-8250-197DDF76AF12Q42279475-2D5E38FC-93F5-4E5B-A5F8-22C5F4F7ED3BQ42928302-B59B025E-BF99-4F9C-B110-9DE89640BBC6Q42930467-4AF35951-A8B6-45DB-BFA1-CC5A677E0682Q50211421-D0B47071-4A02-4C30-A854-8A070C232670
P2860
Comparative activities of AM-715 and pipemidic and nalidixic acids against experimentally induced systemic and urinary tract infections
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年学术文章
@wuu
1981年学术文章
@zh-cn
1981年学术文章
@zh-hans
1981年学术文章
@zh-my
1981年学术文章
@zh-sg
1981年學術文章
@yue
1981年學術文章
@zh
1981年學術文章
@zh-hant
name
Comparative activities of AM-7 ...... c and urinary tract infections
@en
Comparative activities of AM-7 ...... and urinary tract infections.
@nl
type
label
Comparative activities of AM-7 ...... c and urinary tract infections
@en
Comparative activities of AM-7 ...... and urinary tract infections.
@nl
prefLabel
Comparative activities of AM-7 ...... c and urinary tract infections
@en
Comparative activities of AM-7 ...... and urinary tract infections.
@nl
P2093
P2860
P356
P1476
Comparative activities of AM-7 ...... c and urinary tract infections
@en
P2093
Mitsuhashi S
P2860
P304
P356
10.1128/AAC.19.1.188
P407
P577
1981-01-01T00:00:00Z